Chicago-based Cresco Labs announced today will launch its Remedi brand and its Renew and Realign spray tinctures and Renew capsules in New York. In addition, Cresco has received approval for both THC only and 1:1 CBD to THC capsules, spray tinctures, syringes and vape products from its Remedi line from the New York Department of Health.
“I’m excited to introduce Remedi, the first brand from our portfolio in New York,” said Greg Butler, chief commercial officer at Cresco Labs. “Remedi products are specifically tailored to meet the needs of medical patients, and they come in precise doses and form factors similar to other health and wellness products.”
Remedi products will be available in New York starting with Sunnyside stores in Williamsburg, Huntington, New Hartford and Bardonia. Sunnyside offers one of the widest assortments of branded medical cannabis products of any dispensary in New York.
Butler added that Cresco’s new-to-market Sativa spray tincture, as well as new-to-market Hybrid and Indica capsules, are the only category-specific spray tinctures and capsules currently offered in the state. “This launch is the next step in expanding our branded wholesale business in New York,” he said, “just as we have across the rest of the network throughout 2020.”
Cresco is one of the largest multi-state, vertically integrated cannabis companies. Cresco controls its cultivation, manufacturing, extraction and packaging practices by being involved at every point in the seed-to-sales process.
Remedi is a wellness-focused brand that offers easy-to-dose, familiar forms of cannabis for adults. Its line of products includes Remedi spray tinctures, which are fast-acting, easy to use and come in two market offerings: Renew spray tincture (Sativa, 100mg THC) and Realign spray tincture (1:1, 100mg CBD:100mg THC). The process used to make Remedi tinctures results in a superior blend for sublingual absorption.
Additionally, Remedi Renew capsules are available in Hybrid and Indica strains, both offering 100mg THC. The Remedi products recently introduced into New York have been verified as alcohol free, sugar free, gluten free and vegan. Future Remedi products sold in the market may include additional tincture and capsule options.
Remedi was originally created for patients with existing medical conditions in medical cannabis states. The Remedi portfolio has evolved further to serve wellness-minded adults, including new consumers, who are interested in exploring how cannabis can become part of their personal routine. In addition to New York, select Remedi products are currently available in Illinois, Pennsylvania, Michigan, Massachusetts, Arizona and California.